𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chemotherapy and thoractomy for metastatic osteogenic sarcoma. A model for adjuvant chemotherapy and the rationale for the timing of thoracic surgery

✍ Scribed by Gerald Rosen; Andrew G. Huvos; Crisanta Mosende; Edward J. Beattie Jr.; Philip R. Exelby; Brenda Capparos; Ralph C. Marcove

Publisher
John Wiley and Sons
Year
1978
Tongue
English
Weight
864 KB
Volume
41
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Adjuvant chemotherapy for osteogenic sar
Adjuvant chemotherapy for osteogenic sarcoma of the extremity with sequential adriamycin and cisplatin
✍ Anand B. Pathak; Dr. Suresh H. Advani; Rajaram S. Iyer; Suresh K. Pai; Ramakrish πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 358 KB

Twenty-nine patients with high-grade nonmetastatic osteogenic sarcoma of the extremities were treated with adjuvant chemotherapy following definitive surgery. Chemotherapy consisted of systemic intravenous Adriamycin and cisplatin in a sequential fashion given for six courses. Nineteen out of 29 pat

Preoperative chemotherapy for osteogenic
Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy
✍ Gerald Rosen; Brenda Caparros; Andrew G. Huvos; Cynthia Kosloff; Anita Nirenberg πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 936 KB

Since June 1978, 57 patients with primary osteogenic sarcoma of an extremity were treated with highdose methotrexate (HDMTX) and citrovorum factor rescue (CFR), Adriamycin, and the combination of bleomycin, cyclophosphamide and dactinomycin (BCD) given for 4-16 weeks prior to definitive surgery. His

Peripheral blood stem cell support reduc
Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas
✍ Douglas S. Hawkins; Judy Felgenhauer; Julie Park; Susan Kreissman; Blythe Thomso πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 125 KB πŸ‘ 1 views

## Abstract ## BACKGROUND To increase the dose intensity (DI) of chemotherapy for pediatric patients with metastatic sarcomas, including the Ewing sarcoma family of tumors (ESFT) and rhabdomyosarcoma (RMS), the authors tested the feasibility of an intensive regimen supported by granulocyte‐colony